Viewing Study NCT01337505


Ignite Creation Date: 2025-12-25 @ 3:14 AM
Ignite Modification Date: 2026-05-25 @ 5:47 AM
Study NCT ID: NCT01337505
Status: COMPLETED
Last Update Posted: 2022-02-10
First Post: 2011-04-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Maximum Tolerated Dose (MTD) Study of INNO-206 in Subjects With Advanced Solid Tumors
Sponsor: ImmunityBio, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Malignant Solid Tumour View
Keywords:

Keywords

Keyword Brief Keyword Text View
None INNO-206 View
None Phase 1 View
None DOXO-EMCH View
None Advanced solid tumors View